Statin-related adverse drug reactions in UK primary care consultations: A retrospective cohort study to evaluate the risk of cardiovascular events and all-cause mortality.
Widya N InsaniCate WhittleseaChengsheng JuKenneth K C ManHassan AlwafiAlaa AlsharifSarah ChapmanLi WeiPublished in: British journal of clinical pharmacology (2022)
Statin-related ADR was associated with an increased risk of subsequent CVD event, indicating that these patients should be monitored more closely. Continued lipid-lowering medication is of importance to protect against CVD events and mortality.
Keyphrases
- adverse drug
- cardiovascular events
- coronary artery disease
- cardiovascular disease
- primary care
- end stage renal disease
- electronic health record
- newly diagnosed
- ejection fraction
- chronic kidney disease
- healthcare
- prognostic factors
- peritoneal dialysis
- type diabetes
- general practice
- risk factors
- low density lipoprotein